Page 17 - நிறுவனம் ஆஃப் உயிரியல் ப்ராடக்ட்ஸ் இணை லிமிடெட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

National February 17, 2021 LAHORE: The Drug Regulatory Authority of Pakistan (Drap) has declared that Sinopharm vaccine against COVID-19 should not be administered to immune-compromised individuals. The Drap, Ministry of National Health Services, Regulations and Coordination, directed that use of the vaccine in patients with comorbidities should be based on a favourable benefit/risk ratio. The Sinopharm vaccine, manufactured by M/s Beijing Institute of Biological Products Co, Ltd, China, has been approved for grant of registration of SARS-CoV-2 Vaccine (Vero Cell) for emergency use authorisation for active immunisation of individuals between 18 to 60 years of age. The Registration Board, however, noted that the vaccine has already been granted market authorisations and emergency use authorisations in China, UAE and Bahrain.

Institute of biological products co ltdPharmacy services division drapDrug regulatory authority of pakistan drapMinistry of national health servicesNational pharmacovigilance centreGamaleya national centerDrug regulatory authorityNational health servicesBeijing instituteVero cellRegistration boardClinical trialsPost marketingAdverse events following immunisationEmergency use authorisationRussian sputnik v